Overview of Lorastine

What is Lorastine? Overview

Property	Description
Active ingredient	Loratadine
Form	Oral tablet, Oral solution/syrup
Pharmacological class	Second-generation antihistamine
General purpose	Relief from general allergic symptoms
Origin	Synthetic

Lorastine is the trade name for a medicine containing the active ingredient loratadine. It is classified as a second-generation antihistamine that works by selectively blocking the action of histamine, a substance in the body that triggers allergic responses. This synthetic compound is widely recognized in clinical practice for its efficacy in managing the general symptoms associated with common allergies, such as itching and swelling.

What Type of Medicine is Lorastine (Loratadine)?

Lorastine is an anti-allergic medication containing the active ingredient loratadine, which belongs to the second-generation antihistamine class. Loratadine is specifically categorized as a piperidine histamine H1-receptor antagonist. This indicates that the medicine functions by blocking the action of the allergy-triggering chemical histamine. This drug class demonstrates limited penetration of the blood-brain barrier, a design feature that significantly reduces the potential for central nervous system effects, such as drowsiness, associated with older antihistamine compounds.

Forms, Composition, and General Purpose

The medicine is supplied for the oral route of administration in various dosage forms, often including the standard oral tablet, a chewable tablet, and the oral solution (syrup). This provides formulation flexibility, particularly for the younger patient group often targeted by anti-allergic treatments. The core chemical entity loratadine is metabolized in the body to produce desloratadine, an active metabolite that also exerts a potent anti-allergic effect and contributes to the drug's overall extended duration of action. The primary purpose of Lorastine is to provide systemic relief from allergic symptoms, such as those experienced during hay fever season. By binding to peripheral H1-receptors, the medicine prevents histamine from initiating the physical manifestations of an allergic reaction, offering the practical benefit of symptomatic control while remaining non-sedating.

Regulatory References

What side effects are possible with Lorastine?

Possible Side Effects and Safety Information

The safety profile of Lorastine (loratadine) is established through regulatory classifications that organize adverse reactions by frequency and physiological system. The most commonly reported adverse reactions in adults are headache and somnolence (drowsiness). In the pediatric population (children aged 2–12 years), nervousness and somnolence are frequently observed. Reactions classified as uncommon include dry mouth, nausea, gastritis, insomnia, and fatigue.

Adverse Reactions by System and Frequency

Classification	System-Organ Class Examples	Documented Effects
Common	Nervous system disorders	Headache, Somnolence
Uncommon	Gastrointestinal disorders, General disorders	Dry mouth, Nausea, Fatigue
Very Rare	Immune system, Hepatobiliary, Cardiac disorders	Anaphylaxis, Abnormal liver function, Tachycardia, Palpitations

Serious Reactions and Safety Constraints

Very Rare but serious adverse reactions documented in regulatory sources include severe hypersensitivity reactions (such as anaphylaxis), disturbances in heart rhythm like tachycardia and palpitations, and evidence of abnormal liver function (including jaundice and hepatitis).

Specific safety considerations are noted for certain groups. Caution is required, and a dose adjustment may be necessary for individuals with severe hepatic impairment. Furthermore, the antihistamine must be discontinued for a specific period (e.g., approximately two days) before conducting skin-prick allergy tests, as its activity can interfere with the results and lead to false negative findings.

Overdose and Emergency Response

Overdose and when to seek help

Official regulatory documents describe the clinical profile of a Lorastine overdose based on documented manifestations and mandated emergency actions. Overdosage with the active ingredient, loratadine, has been reported to increase the occurrence of anticholinergic symptoms.

Documented Overdose Manifestations

Symptoms reported following overdose include somnolence (drowsiness), headache, and tachycardia (rapid heart rate). Somnolence has been noted to increase in a dose-related manner in adults receiving doses higher than recommended. In the pediatric population, specific signs reported include palpitations and extrapyramidal signs.

Potential severe outcomes that necessitate close medical management include the risk of cardiac arrhythmias and QT-interval prolongation.

Required Emergency Actions and Management

Urgent medical attention is required in the event of an overdose. Regulatory guidance mandates that individuals seek medical help or contact a Poison Control Center right away.

For severe, life-threatening scenarios, such as when a person has collapsed, experienced a seizure, or has trouble breathing, the instruction is to call emergency services immediately.

Management involves instituting and maintaining general symptomatic and supportive measures. No specific antidote is known for reversing the effects of loratadine. Procedures such as gastric lavage or administration of activated charcoal as a slurry with water may be considered or attempted. Medical monitoring of the patient must be continued after initial emergency treatment, and it is documented that the drug is not removed by haemodialysis.

Therapeutic Uses of Lorastine

Main Uses and Benefits of Lorastine

Lorastine is an antihistamine medication primarily used to manage symptoms associated with allergic reactions. It belongs to a class of drugs known as second-generation H1 receptor antagonists, which are designed to provide relief from allergy symptoms with a reduced likelihood of causing drowsiness compared to older antihistamines.

Treatment of Allergic Rhinitis

Lorastine is frequently utilized to alleviate the symptoms of allergic rhinitis, commonly referred to as hay fever. This condition involves inflammation of the nasal passages triggered by allergens such as pollen, dust mites, or pet dander. The medication helps address several specific symptoms:

Sneezing: Reduces the frequency of sudden sneezing fits.
Rhinorrhea: Manages a runny nose by decreasing mucus production.
Nasal Pruritus: Relieves itching within the nose.
Ocular Symptoms: Eases itchy, red, and watery eyes often associated with seasonal or perennial allergies.

Management of Chronic Urticaria

Beyond respiratory allergies, Lorastine is used in the treatment of chronic idiopathic urticaria, a skin condition characterized by the regular appearance of hives or wheals. The benefits in this context include:

Reduction of Skin Lesions: Helps decrease the number and size of hives.
Relief from Itching: Significantly reduces the pruritus (itching) associated with skin eruptions.
Improved Comfort: Addresses the localized swelling and redness of the skin.

Mechanism and Efficacy

The primary benefit of Lorastine is its long-acting nature, typically providing symptom relief for up to 24 hours. By blocking the action of histamine—a substance in the body that causes allergic symptoms—it prevents the physiological response to allergens. Because it does not readily enter the brain, it is less likely to interfere with daily activities or cognitive functions compared to first-generation antihistamines.

Regulatory References

NIH MedlinePlus overview

Eligibility and Restrictions for Use

Eligibility and Contraindications

Official regulatory documents define specific populations who can and cannot use Lorastine (loratadine), primarily based on age, hypersensitivity, and organ function status.

Category	Official Regulatory Classification
Populations for whom use is allowed	Adults and adolescents ge 12 years of age. Children 2 to 11 years of age are eligible for use, with specific dosage limitations [Source: FDA, EMA].
Populations for whom use is contraindicated	Individuals with a known hypersensitivity or allergy to loratadine, its active metabolite desloratadine, or any component of the formulation [Source: EMA/SmPC]. Breastfeeding individuals due to drug excretion into human milk [Source: MedlinePlus].

Age and Condition Restrictions

Age-Related Eligibility: Use is not established and not recommended in children under 2 years of age [Source: FDA].

Condition-Specific Eligibility: Patients with severe hepatic impairment (liver disease) or severe renal impairment (kidney disease, generally GFR le 30 mL/min) are a restricted population. The label specifies that these individuals must be managed with a lower, alternate-day regimen [Source: FDA, Drugs.com Monograph].

Pregnancy Status: Use during pregnancy is generally not recommended or advised only when clearly necessary [Source: EMA/SmPC].

What should I know about interactions with other medicines?

The official regulatory profile for Loratadine (Lorastine) focuses on pharmacokinetic interactions that alter the concentration of the medicine in the body. Loratadine is metabolized by the Cytochrome P450 3A4 (CYP3A4) enzyme, and to a lesser extent, by CYP2D6. Co-administration with known inhibitors of these pathways, specifically including Ketoconazole, Erythromycin, and Cimetidine, is formally documented to result in substantially increased plasma concentrations of loratadine. While this elevation in drug exposure is consistent across regulatory documents, controlled trials reported that these changes occurred generally without clinically significant changes to safety parameters.

Metabolic, Timing, and Substance Effects

Regulatory documents establish mandatory constraints on administration related to specific substances and procedures. Ingestion of food is noted to delay the absorption of the medicine while simultaneously increasing its overall systemic exposure, or Area Under the Curve (AUC). Pharmacodynamic studies formally documented in the label confirm that Loratadine has no potentiating effects on psychomotor performance when co-administered with alcohol. A critical procedural constraint exists for diagnostics: Loratadine administration must be discontinued for at least 48 hours prior to the performance of skin allergy tests to prevent interference that could result in reduced or false negative dermal reactions. Caution is also noted for patients with severe liver impairment due to potentially reduced clearance.

Mechanism of Action

Peripheral Histamine H1 Receptor Inverse Agonism

Lorastine works primarily by stabilizing the inactive form of the peripheral Histamine H1 receptor , acting as a competitive antagonist to prevent receptor activation by histamine. This action prevents the H1-mediated signaling cascade; this mechanism is associated with a decrease in histamine-induced vascular permeability and a reduction of sensory nerve activation.

Cascade Dampening and Mediator Release Inhibition

The mechanism extends beyond H1 receptor blockade by engaging in a cascade dampening mechanism that influences mediator release. This involves stabilizing mast cells and basophils and inhibiting the release of secondary pro-inflammatory mediators, such as leukotrienes and certain cytokines. This influence may result in a decrease in excessive mediator activity, contributing to the overall physiological effect profile.

High Peripheral Selectivity

Lorastine exhibits high selectivity for peripheral physiological systems over central nervous system (CNS) pathways due to its chemical structure and poor ability to cross the blood-brain barrier. This highly targeted mechanism ensures that the modulation of the histamine signaling pathway occurs predominantly outside the CNS; this peripheral localization is associated with a minimal interaction with central H1 receptors.

Dosage and Administration Information

How to Use Lorastine: Administration Guidelines

Lorastine (loratadine) is an oral medication. The drug is available in various forms, including oral tablets, syrup/solution, and chewable tablets.

Standard Dosing Regimens

The standard pattern of use is a once-daily schedule, meaning the medicine is taken no more frequently than once every 24 hours. The dose for adults and adolescents (12 years and older) is 10 mg once daily. Children between 2 and 6 years of age (weighing 30 kg or less) typically receive 5 mg once daily. The maximum dose permitted in a 24-hour period for standard use is 10 mg.

Administration Context and Special Conditions

Feature	Instruction
Timing in relation to meals	May be taken with or without food.
Preparation requirements	Liquid forms must be measured with an accurate dosing device. Chewable tablets must be chewed or crushed before swallowing.
Adjustment for Organ Impairment	For patients with severe hepatic (liver) impairment or severe renal (kidney) impairment (GFR < 30 mL/min), the recommended initial dosing interval is every 48 hours (e.g., 10 mg every other day).
Pre-Procedure Restriction	The administration of loratadine must be discontinued at least 48 hours before scheduled skin allergy testing, as the medicine can interfere with the results.

Missed Dose Instructions

If a dose is missed, it should be taken as soon as it is remembered. However, if it is nearly time for the next scheduled dose, the missed dose should be skipped; a double dose must not be taken to compensate for the omitted one. This overall protocol defines the standardized approach to using the medicine.

Recent Clinical Evidence

Lorastine: Recent Clinical Evidence

This section provides a factual overview of the clinical research on Lorastine (loratadine), describing the types of studies conducted and what the research so far describes, without offering any clinical advice or making specific assurances about individual outcomes.

Evidence for Use in Allergic Rhinitis (Hay Fever)

The evaluation of Lorastine for patterns associated with hay fever symptoms (seasonal and perennial allergic rhinitis) has been the focus of extensive investigation. Research has included large Randomized Controlled Trials (RCTs) and Systematic Reviews. Studies primarily measured outcomes related to symptom intensity, such as Total Nasal Symptom Scores (TNSS) and Total Ocular Symptom Scores (TOSS), in adults and adolescents. Studies monitored how symptoms evolved in the observed populations, with research describing that the comparison of symptom measurements for participants receiving Lorastine and the placebo group showed variability in the reported findings. Research explored whether outcomes related to daily functioning were also assessed.

Evidence for Use in Chronic Urticaria (Hives)

Research has explored Lorastine's role in conditions characterized by fluctuating manifestations, specifically chronic urticaria or hives. The evidence base consists of Controlled Clinical Trials which examined outcomes related to pruritus (itching) and monitoring changes in urticarial lesions (hives) in adults and adolescents. Findings describe patterns of reported symptom evolution observed in these studies.

Research Gaps and Evidence Uncertainty

Current evidence highlights areas where more research is needed. One key limitation is the limited dedicated study data for children younger than 6 years old. The evidence for this group is often derived from the extrapolation of findings from older children and adults. Long-term outcomes for specific age groups are not fully established. Additionally, comparative evidence against certain other second-generation antihistamines has sometimes reported mixed findings, which reflects that the methodology and reported findings differ across comparative studies.

Frequently Asked Questions (FAQ)

Common questions about Lorastine (FAQ)

Q: What is the main difference between Lorastine and other similar medicines?

Lorastine is classified in regulatory documents as a second-generation antihistamine with selective activity on peripheral H1-receptors. This mechanism is noted for having minimal sedative or anticholinergic properties in the majority of users, which distinguishes it from older types of antihistamine compounds.

Q: How long do the effects of Lorastine usually last?

Official product information indicates that the anti-histaminic effect of Lorastine typically begins within 1 to 3 hours after administration. This effect is described as lasting in excess of 24 hours, which supports its standard once-daily use pattern.

Q: Are there long-term side effects associated with using Lorastine?

Regulatory monitoring during long-term use has examined standard safety parameters. Studies indicate that there have been no clinically significant changes reported in vital signs, laboratory test values, or electrocardiograms (ECGs) during extended treatment periods.

Q: What is the difference between Lorastine and a brand name equivalent?

Lorastine is the specific trade name for a medicine containing the active ingredient loratadine. Medicines that share the exact same active ingredient are considered chemically and biologically equivalent.

Q: What does the term 'contraindication' mean for Lorastine?

Contraindication is a term used in official documents to describe a condition or factor that generally makes a medicine unsuitable for use because the known risks outweigh the potential benefits. For Lorastine, this category includes known hypersensitivity or allergy to the drug or its components.

Q: What kind of ingredients are in the Lorastine tablet?

Lorastine contains the active substance loratadine. Regulatory documents list that the tablets also include non-active ingredients, or excipients, which may include components such as lactose monohydrate, microcrystalline cellulose, maize starch, and magnesium stearate.

Q: Are there common reasons why Lorastine might not work for someone?

Official information notes that altered effects may occur in individuals with severe kidney (renal) or liver (hepatic) impairment. These conditions can affect how the body processes and clears the medicine, potentially leading to variable response.

Q: How long does it typically take for Lorastine to start working?

Studies documented in official sources indicate that the anti-histaminic effect of Lorastine begins within 1 to 3 hours after it is taken.

Q: Is it okay to drive or operate machinery after taking Lorastine?

Official product information notes that because some individuals may experience drowsiness, the ability to perform activities requiring concentration, such as driving or operating machinery, should be considered.

Q: Can Lorastine be taken with pain relievers like ibuprofen?

Official regulatory documents focus on known interactions that significantly alter the drug's concentration or effects, such as with certain antifungal or antibiotic medicines. There is no known specific drug-drug interaction warning between loratadine and common non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen mentioned in official summaries.

Q: Is Lorastine safe for older adults to use?

Official product information indicates that no specific dosage adjustment is required for the elderly population. The official information emphasizes the importance of not exceeding the recommended doses for older adults, as with any medication.

Q: Is Lorastine an over-the-counter medicine or does it require a prescription?

Lorastine, containing loratadine, is widely approved and available as an over-the-counter (non-prescription) medicine for its approved indications in many regions.

Q: Can Lorastine be used by people with high blood pressure?

Regulatory documents describe the drug as having practically no influence on cardiovascular function. However, changes in blood pressure (both high and low) have been reported as possible side effects in regulatory safety information.

Q: Does Lorastine lose its effectiveness over time?

According to the official product information and regulatory studies, no evidence was found that tolerance—or a measurable loss of effectiveness—develops over short-term treatment periods lasting up to 28 days.

Q: How is Lorastine different from a nasal spray for allergies?

Lorastine is an oral medicine that is absorbed systemically, meaning it provides general, whole-body relief from allergic symptoms. In contrast, nasal sprays are typically applied topically to deliver relief primarily to the local nasal passages.

Q: Is Lorastine addictive?

Loratadine is not classified as a controlled substance by regulatory bodies. Official product information does not list the medicine as having addictive properties or abuse potential.

Q: Does taking Lorastine affect blood tests?

Regulatory reviews of long-term use have shown no clinically significant changes in standard laboratory test values. Interference is only noted for specific skin allergy tests, which requires discontinuing the medicine before testing.

Q: Can taking Lorastine cause a person to gain weight?

Regulatory safety information lists both weight gain and/or increased appetite as possible adverse reactions that have been reported by users.

Q: Does Lorastine interact with caffeine?

Pure loratadine is generally not flagged for interaction with caffeine in official documents. However, combination products that include a decongestant component may have an interaction warning due to the decongestant's known stimulating effects.

Q: Is there a maximum time frame for how long Lorastine can be used?

Official regulatory documents do not define a specific maximum duration of use. The medicine has been studied in clinical trials for up to six months, and long-term intermittent use may be required for chronic conditions.

Q: Can Lorastine cause changes in appetite?

Regulatory safety information lists both increased appetite and loss of appetite as possible adverse reactions reported in the post-marketing period.

Q: Are there any religious or dietary concerns related to Lorastine's ingredients?

The tablet's non-active ingredients, or excipients, may include lactose monohydrate. Official documents note that this ingredient may be sourced from ruminant animal origin, which may be relevant for specific dietary considerations.

Q: Where can I find the official prescribing information for Lorastine?

The official regulatory documents, such as the FDA Label (DailyMed) or the EMA Summary of Product Characteristics (SmPC), are publicly available on the websites of government health authorities.

How should Lorastine be stored and disposed of?

How to Store and Dispose of Lorastine

Storing Lorastine correctly is essential for maintaining its stability and effectiveness until the expiration date. Follow these official regulatory requirements:

Storage Conditions

Temperature: Store at Controlled Room Temperature, typically between 20,^circmathrmC and 25,^circmathrmC (68,^circmathrmF and 77,^circmathrmF).
Environmental Protection: Keep the medication from freezing, excess heat, and moisture. Do not store in bathrooms.
Packaging: Keep Lorastine in its original container, which should be tightly closed, and keep it out of direct light.
Safety: Always store the product securely, up and away, and out of the reach of children.

Disposal Instructions

Unused/Expired Medicine: The preferred method for disposal is utilizing a community drug take-back program or an authorized collection point.
Household Disposal: If a take-back program is unavailable, mix the medicine (removed from its original container) with an undesirable substance, such as dirt or used coffee grounds, seal the mixture in a bag, and then discard it in the household trash.
Environmental Rule: Do not flush Lorastine down the sink or toilet.

Lorastine